[PDF][PDF] Influenza virus vaccination elicits poorly adapted B cell responses in elderly individuals

C Henry, NY Zheng, M Huang, A Cabanov, KT Rojas… - Cell Host & Microbe, 2019 - cell.com
C Henry, NY Zheng, M Huang, A Cabanov, KT Rojas, K Kaur, SF Andrews, AKE Palm…
Cell Host & Microbe, 2019cell.com
Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction
of this population. A key aspect of antibody-mediated anti-influenza virus immunity is
adaptation to antigenically distinct epitopes on emerging strains. We examined factors
contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic
reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon
vaccination. This reduction is associated with a significant decrease in the capacity of …
Summary
Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically distinct epitopes on emerging strains. We examined factors contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon vaccination. This reduction is associated with a significant decrease in the capacity of antibodies to target the viral glycoprotein, hemagglutinin (HA), and critical protective epitopes surrounding the HA receptor-binding domain. Immune escape by antigenic drift, in which viruses generate mutations in key antigenic epitopes, becomes highly exaggerated. Because of this reduced adaptability, most B cells activated in the elderly cohort target highly conserved but less potent epitopes. Given these findings, vaccines driving immunoglobulin gene somatic hypermutation should be a priority to protect elderly individuals.
cell.com